via John Innes Centre
Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases – tuberculosis (TB).
Researchers from the John Innes Centre evaluated two compounds with antibacterial properties, which had been produced by the company Redx Pharma as antibiotic candidates, particularly against TB.
TB, which is caused by the bacterium Mycobacterium tuberculosis, is often thought of as a disease of the past. But in recent years it has been increasing due, in part, to rising resistance to treatments and decreasing efficacy of vaccines.
One strategy in the search for new treatments is to find compounds that exploit well-known existing targets for drugs such as the bacterial enzyme DNA gyrase. This member of the DNA topoisomerase family of enzymes is required for bacterial DNA functionality, so compounds that inhibit its activity are much sought after as antibiotic candidates.
Using X-ray crystallography, the team elucidated the molecular details of the action of the compounds against their target.
Surprisingly, a very common mutation in DNA gyrase that causes bacteria to be resistant to a related group of antibiotics, the aminocoumarins, did not lead to resistance to the compounds under scrutiny here.
“We hope that companies and academic groups working to develop new antibiotics will find this study useful. It opens the way for further synthesis and investigation of compounds that interact with this target,” says Professor Tony Maxwell one of the authors of the study which appears in the Journal of Antimicrobial Chemotherapy.
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years.
World Health Organisation (WHO) figures reveal that each day over 4,000 people die from TB and 300,000 people fall ill from the disease. Nearly 500,000 people fell ill with drug-resistant TB in 2018.
Professor Maxwell says: “Antimicrobial resistance (AMR) is now well-recognised as one of the biggest problems facing us in the in the 21st Century. If we don’t find solutions to it soon, we could be looking at epidemics of bacterial disease going forward.”
“People know about the bubonic plague and other such terrible pestilence through studying history but it’s not overstating the case that bacterial diseases of this sort could reemerge if we do not have effective antibiotics. We must find a way of bringing together expertise from the academic and business sector towards decisive action.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Coronavirus Update: Tuberculosis vaccine being tested in Canada for effectiveness against COVID-19on October 6, 2020 at 4:41 pm
Donald Trump continues to play down severity of virus while still infected; First antigen rapid test for COVID-19 approved by Health Canada ...
- Prisoner contracts tuberculosison October 6, 2020 at 10:56 am
"Unfortunately, medical information is not readily given out to staff, and it's a concern of ours that somebody comes in with something transferrable via the atmosphere, and we don't know about it ...
- Canadian researchers begin clinical trials of tuberculosis vaccine for COVID-19on October 6, 2020 at 7:09 am
Researchers in Canada are hoping a century-old vaccine designed to treat tuberculosis can become the key to fighting off a COVID-19 infection.
- Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosison October 6, 2020 at 6:14 am
The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule ...
- Health and safety review under way after Tuberculosis case in Waikato prisonon October 5, 2020 at 9:37 pm
There is at least one case of tuberculosis, known as TB, in the Spring Hill prison in North Waikato. Spring Hill Prison director Megan Tuhoro said the secure and controlled nature of the prison ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Pharmaceutical strategy must address antimicrobial resistance, MEPs urgeon October 6, 2020 at 2:49 am
Thirty European Parliament lawmakers have written to Health Commissioner Stella Kyriakides calling for the EU pharmaceutical strategy to integrate the development of, and access to, affordable and ...
- Antibiotic resistance becoming a grave threat to healthon October 4, 2020 at 5:00 pm
"The reasons for the rising antibiotic resistance, include over-prescribing, misuse by patients who don't follow the advice of healthcare professionals, overuse in farming, poor infection control. For ...
- Bennet, Young Introduce Legislation to Fight Antimicrobial Resistanceon October 2, 2020 at 10:10 am
Bennet, Young Introduce Legislation to Fight Antimicrobial Resistance. Bipartisan Bill Would Encourage Development of Innovative Antibiotics to Treat Resistant Infections and Impr ...
- Global Antibiotic Resistance Markets Report 2020: Top Selling Drugs 2011-2015 & Updated Forecast to 2024 - ResearchAndMarkets.comon October 2, 2020 at 2:20 am
Oct 2, 2020-- The “Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type 2020 To 2024” report has been added to ResearchAndMarkets.com’s offering. Antimicrobial Resistance is ...
- Global Antibiotic Resistance Markets Report 2020: Therapeutic Analysis 2017-2019 & 2020-2023 by Pathogen and Therapy Type with Situation Analysis - ResearchAndMarkets.comon October 2, 2020 at 1:32 am
The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type With Situation Analysis, Executive & Investor Guides & Customization 2019 to 2023" report has been added to ...